About Allergan and Allergan Urology

Allergan is a US-based specialty drug and medical device company offering innovative products in approximately 100 countries. Allergan is investing significant resources to develop a product portfolio that addresses the full continuum of care for patients with Overactive Bladder (OAB) and other urological and genitourinary disorders.

In 2013, BOTOX® received FDA approval as a treatment for Overactive Bladder to treat the OAB symptoms of leakage, the strong sudden need to go, and going too often in adults when another type of medication (anticholinergic) does not work well enough or cannot be taken. Today, BOTOX® neurotoxin is approved to treat a total of eight medical conditions in the Unites States.